Brokerages expect HB Fuller Co (NYSE:FUL) to report $702.32 million in sales for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for HB Fuller’s earnings. The highest sales estimate is $709.90 million and the lowest is $687.10 million. HB Fuller posted sales of $713.08 million in the same quarter last year, which would indicate a negative year over year growth rate of 1.5%. The firm is scheduled to issue its next quarterly earnings report on Wednesday, March 27th.
According to Zacks, analysts expect that HB Fuller will report full-year sales of $3.08 billion for the current year, with estimates ranging from $3.04 billion to $3.10 billion. For the next fiscal year, analysts anticipate that the company will report sales of $3.19 billion, with estimates ranging from $3.12 billion to $3.27 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that follow HB Fuller.
HB Fuller (NYSE:FUL) last issued its quarterly earnings data on Wednesday, January 16th. The specialty chemicals company reported $0.90 earnings per share for the quarter, missing the consensus estimate of $0.99 by ($0.09). The business had revenue of $768.43 million during the quarter, compared to analysts’ expectations of $806.99 million. HB Fuller had a return on equity of 13.77% and a net margin of 5.63%. The company’s revenue for the quarter was up 13.3% compared to the same quarter last year.
Several brokerages recently weighed in on FUL. Zacks Investment Research lowered HB Fuller from a “hold” rating to a “sell” rating in a research report on Friday, November 30th. Deutsche Bank lowered HB Fuller from a “buy” rating to a “hold” rating and set a $50.00 price objective for the company. in a research report on Tuesday. ValuEngine upgraded HB Fuller from a “sell” rating to a “hold” rating in a research report on Tuesday, January 22nd. Finally, Stifel Nicolaus began coverage on HB Fuller in a research report on Monday, December 10th. They issued a “buy” rating and a $62.00 price objective for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $59.14.
HB Fuller stock traded down $0.43 during mid-day trading on Friday, hitting $49.34. The company’s stock had a trading volume of 279 shares, compared to its average volume of 597,508. The firm has a market capitalization of $2.49 billion, a price-to-earnings ratio of 16.45, a PEG ratio of 0.78 and a beta of 1.44. HB Fuller has a 1 year low of $39.61 and a 1 year high of $59.58. The company has a debt-to-equity ratio of 1.86, a quick ratio of 1.34 and a current ratio of 1.99.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 21st. Investors of record on Thursday, February 7th will be given a $0.155 dividend. The ex-dividend date of this dividend is Wednesday, February 6th. This represents a $0.62 annualized dividend and a yield of 1.26%. HB Fuller’s payout ratio is 20.67%.
In related news, VP Traci L. Jensen sold 4,129 shares of the stock in a transaction that occurred on Tuesday, November 13th. The stock was sold at an average price of $46.01, for a total value of $189,975.29. Following the completion of the transaction, the vice president now directly owns 20,997 shares in the company, valued at $966,071.97. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 3.46% of the company’s stock.
Large investors have recently added to or reduced their stakes in the business. Trust Co. of Vermont acquired a new position in HB Fuller during the fourth quarter worth $26,000. Riverhead Capital Management LLC lifted its stake in HB Fuller by 39.1% during the third quarter. Riverhead Capital Management LLC now owns 4,271 shares of the specialty chemicals company’s stock worth $221,000 after purchasing an additional 1,200 shares in the last quarter. Jane Street Group LLC acquired a new position in HB Fuller during the second quarter worth $269,000. Quantamental Technologies LLC acquired a new stake in shares of HB Fuller in the fourth quarter valued at $286,000. Finally, Diversified Trust Co raised its stake in shares of HB Fuller by 8.1% in the fourth quarter. Diversified Trust Co now owns 7,025 shares of the specialty chemicals company’s stock valued at $300,000 after acquiring an additional 525 shares in the last quarter. Institutional investors own 98.14% of the company’s stock.
HB Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.
Further Reading: Trading Ex-Dividend Strategy
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.